New Formulation and Food Effect Study of BIIB074
Completed · Phase 1
Conditions studied: Trigeminal Neuralgia (TN), Other Neuropathic Pain
In brief
The primary objectives of the study are to assess the relative bioavailability of the BIIB074 direct compression formulation (DCF) to the BIIB074 roller compaction formulation (RCF) and to determine the effect of a high-fat meal on the pharmacokinetics (PK) of the BIIB074 DCF. The secondary objective of the study is to assess the safety and tolerability of BIIB074 administered as the DCF following single oral dose administration in healthy participants.
Key facts
- Study ID
- NCT02951221
- Run by
- Biogen
- People needed
- 28
- Starts
- 2016-12-01
- Expected to finish
- 2017-02-01
- Last updated by the study team
- 2017-02-27
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Research Site — Daytona Beach, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.